Stay updated on MK-3475 and Gemcitabine in NSCLC Clinical Trial

Sign up to get notified when there's something new on the MK-3475 and Gemcitabine in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the MK-3475 and Gemcitabine in NSCLC Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer now identifies the site revision as v3.7.2 instead of v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-18T22:38:50.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision number changed from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-11T22:40:29.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error instead of the study details, indicating access to the record is blocked. This replaces the expected content with a standard error screen.
    Difference
    18%
    Check dated 2026-09-20T22:28:52.000Z thumbnail image
  5. Check
    55 days ago
    Change Detected
    Summary
    The page footer now displays Revision: v3.6.6, signaling an update to the site's version. This change is limited to the system label and does not affect the displayed study details.
    Difference
    0.1%
    Check dated 2026-08-30T15:37:21.000Z thumbnail image
  6. Check
    77 days ago
    Change Detected
    Summary
    Revision: v3.6.5 was added and v3.6.4 was removed, indicating a new page version. This appears to be a small metadata update rather than a substantive change to the study details.
    Difference
    0.1%
    Check dated 2026-08-08T23:34:44.000Z thumbnail image
  7. Check
    92 days ago
    Change Detected
    Summary
    The page’s revision tag updated from v3.6.3 to v3.6.4, indicating a backend or template update. This does not indicate changes to the study data or content that users rely on.
    Difference
    0.1%
    Check dated 2026-07-25T12:30:01.000Z thumbnail image

Stay in the know with updates to MK-3475 and Gemcitabine in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the MK-3475 and Gemcitabine in NSCLC Clinical Trial page.